Literature DB >> 10947866

Insulin induces epidermal growth factor (EGF) receptor clustering and potentiates EGF-stimulated DNA synthesis in swiss 3T3 cells: a mechanism for costimulation in mitogenic synergy.

M F Crouch1, D A Davy, F S Willard, L A Berven.   

Abstract

In many cellular systems, activation with more than one ligand can produce a cellular response that is greater than the sum of the individual responses to the ligands. This synergy is sometimes referred to as coactivation. In Swiss 3T3 fibroblasts, activation of the epidermal growth factor (EGF) receptor produces a weak induction of DNA synthesis. Insulin has no stimulatory effect on this response. However, in combination, EGF and insulin synergize to cause a large induction of S phase. The underlying cellular biochemistry of this effect has been examined. The data indicate that phospholipase C activation is a major component of agonist-induced DNA synthesis. In contrast, activation of p70 S6 kinase by single agonists was inversely related to their ability to stimulate DNA synthesis. Therefore, it was examined whether stimulation of Swiss 3T3 cells with insulin causes changes in the subcellular distribution of EGF receptors and phospholipase Cgamma1 that could potentially explain the observed synergy or costimulation. It was found that insulin effectively induced the accumulation of EGF receptors on the actin arc of cells without activation of the EGF receptor. In contrast, EGF, when added for several hours, did not cause accumulation of the EGF receptor at this site. However, both EGF and insulin stimulated the accumulation of phospholipase Cgamma1 at the actin arc, which was coincident with the EGF receptor in the case of insulin- stimulated cells. Therefore, it is suggested that the insulin-induced coclustering of the EGF receptor with phospholipase Cgamma1 at the actin arc may allow for greater efficiency of signal transduction, resulting in the synergy observed for these two hormones in stimulation of DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947866     DOI: 10.1046/j.1440-1711.2000.00929.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  7 in total

1.  Alpha6beta4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer.

Authors:  Michael Z Gilcrease; Xiao Zhou; Xiaolin Lu; Wendy A Woodward; Brian E Hall; Phillip J Morrissey
Journal:  J Exp Clin Cancer Res       Date:  2009-05-26

2.  Activation of endogenous thrombin receptors causes clustering and sensitization of epidermal growth factor receptors of swiss 3T3 cells without transactivation.

Authors:  M F Crouch; D A Davy; F S Willard; L A Berven
Journal:  J Cell Biol       Date:  2001-01-22       Impact factor: 10.539

3.  The sensitivity to Hsp90 inhibitors of both normal and oncogenically transformed cells is determined by the equilibrium between cellular quiescence and activity.

Authors:  Pablo C Echeverria; Kaushik Bhattacharya; Abhinav Joshi; Tai Wang; Didier Picard
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

4.  Novel Insight Into Nutritional Regulation in Enhancement of Immune Status and Mediation of Inflammation Dynamics Integrated Study In Vivo and In Vitro of Teleost Grass Carp (Ctenopharyngodon idella): Administration of Threonine.

Authors:  Yu-Wen Dong; Wei-Dan Jiang; Pei Wu; Yang Liu; Sheng-Yao Kuang; Ling Tang; Wu-Neng Tang; Xiao-Qiu Zhou; Lin Feng
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

5.  Systems-level interactions between insulin-EGF networks amplify mitogenic signaling.

Authors:  Nikolay Borisov; Edita Aksamitiene; Anatoly Kiyatkin; Stefan Legewie; Jan Berkhout; Thomas Maiwald; Nikolai P Kaimachnikov; Jens Timmer; Jan B Hoek; Boris N Kholodenko
Journal:  Mol Syst Biol       Date:  2009-04-07       Impact factor: 11.429

6.  Recruitment of the adaptor protein Grb2 to EGFR tetramers.

Authors:  Noga Kozer; Dipak Barua; Christine Henderson; Edouard C Nice; Antony W Burgess; William S Hlavacek; Andrew H A Clayton
Journal:  Biochemistry       Date:  2014-04-21       Impact factor: 3.162

Review 7.  Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention.

Authors:  Brendan Ffrench; Claudia Gasch; John J O'Leary; Michael F Gallagher
Journal:  Mol Cancer       Date:  2014-12-11       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.